pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,379 catalysts · 5,063 phase readout · 2,312 8k filing · 316 pdufa · 273 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 16 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×clear all
type
  • phase readout5,063
  • 8k filing2,312
  • pdufa316
  • earnings273
  • phase 2 completion108
  • phase 1 completion50
  • phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04617678: A Comprehensive Approach to Head and Neck Cancer Prehabilitation

    Sponsor: Sanford Health. Phase: NA. Conditions: Cancer of Head and Neck

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07525778: Evaluating WhatsOK Helpline for Youth With Concerns About Sexual Thoughts and Behaviors

    Sponsor: Center for Violence Prevention Research Inc. Phase: NA. Conditions: Mental Health, Social Support, Perceived Self-efficacy, Sexual Behavior

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07575178: Obstacle Course Versus Neuromotor Task Training in Children With DCD

    Sponsor: Riphah International University. Phase: NA. Conditions: Developmental Coordination Disorder (DCD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03910478: Dried Blood Spot Testing of CMV Detection in HCT Recipients

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: NA. Conditions: Cytomegalovirus Infection

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06892743: Analgesic Efficacy of Ultrasound-guided External Oblique Intercostal Plane Block Versus Posterior Transversus Abdominis Plane Block in Patients Undergoing Open Nephrectomy

    Sponsor: Cairo University. Phase: NA. Conditions: Postoperative Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07224243: Impact of Intraoperative Oxygenation Practices on Patient Outcomes

    Sponsor: Frederic T Billings IV. Phase: NA. Conditions: Surgeries Undergoing General Anesthesia

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT03295279: WTC Chest CT Imaging Archive

    Sponsor: Icahn School of Medicine at Mount Sinai. Phase: . Conditions: Chronic Airway Disease, Interstitial Lung Disease, Lung Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06631079: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors

    Sponsor: NEC Bio B.V. Phase: PHASE1. Conditions: Solid Tumor

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07483879: Biomarkers of Acute Organ Injury in Pediatric Newly Diagnosed Type 1 Diabetes

    Sponsor: Aristotle University Of Thessaloniki. Phase: . Conditions: Type 1 Diabetes Mellitus, Diabetic Ketoacidosis

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06692179: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

    Sponsor: University of Minnesota. Phase: PHASE1. Conditions: Recurrent Clostridioides Difficile Infection, Colonic Surgery

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT05576896: Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab in the Treatment of Metastatic BRAF-mutated Colorectal Cancer Refractory

    Sponsor: Northwestern University. Phase: PHASE2. Conditions: Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07334496: A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects

    Sponsor: Gan & Lee Pharmaceuticals.. Phase: PHASE1. Conditions: Biosimilarity

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07520162: A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab

    Sponsor: AstraZeneca. Phase: PHASE3. Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06743646: Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

    Sponsor: Chigenovo Co., Ltd. Phase: PHASE3. Conditions: Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05464888: Animal Assisted Therapy in Pediatric Dentistry

    Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Anxiety

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07621861: Holy Qur'an Versus Music Sound on Sleep Quality in Children Undergoing Chemotherapy

    Sponsor: Rawand Shafeeq Ali. Phase: NA. Conditions: Sleep Wake Disorders

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05216042: GENESIS: Genotype Guided - Natriuretic Peptides - Cardiometabolic Health Study

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Cardiovascular Diseases, Natriuretic Peptides, Cardiometabolic Diseases, Energy Expenditure, Glucose Metabolism, Exercise, Obesity

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04993742: Effects of Pregnancy-Specific Anxiety on Placental Inflammatory and Oxidative Stress Response and Birth Outcomes

    Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine. Phase: NA. Conditions: Placental Dysfunction, Prenatal Stress

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06054386: Attention Bias Modification Training for Social Phobia (ABMSP)

    Sponsor: University of Wisconsin, Milwaukee. Phase: NA. Conditions: Social Anxiety Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04459273: Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers

    Sponsor: Jonsson Comprehensive Cancer Center. Phase: PHASE1. Conditions: Bladder Carcinoma, Cervical Carcinoma, Cholangiocarcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Hepatocellular Carcinoma, Malignant Adrenal Gland Neoplasm, Malignant Brain Neoplasm, Malignant Pleural Neoplasm, Malignant Skin Neoplasm, Malignant Solid Neoplasm, Malignant Testicular Neoplasm, Malignant Thymus Neoplasm, Neuroendocrine Neoplasm, Thyroid Gland Carcinoma, Urothelial Carcinoma, Cancer of Unknown Primary Site

    full page →ctgov ↗
    ›AVAILABLEphase readoutNCT05982873: Expanded Access to Telisotuzumab Adizutecan

    Sponsor: AbbVie. Phase: . Conditions: Solid Tumors

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04156373: Fuerte Program for Newcomer Immigrant Youth

    Sponsor: University of California, San Francisco. Phase: NA. Conditions: Trauma, Psychological, Mental Disorder in Adolescence, Adolescent - Emotional Problem

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05098769: A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.

    Sponsor: Shengjing Hospital. Phase: . Conditions: Pulmonary Embolism and Thrombosis, Deterioration, Clinical

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07242469: A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)

    Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Diabetes Mellitus, Type 2

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07355283: IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

    Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.. Phase: PHASE3. Conditions: Relapsed/Refractory Follicular Lymphoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06919783: Adapting a Health at Every Size Intervention to Obstetric Care

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Weight Stigma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07583641: A Study to Learn About How Well the Medicine Efgartigimod Works to Treat Autoimmune Encephalitis In Children 12 Years or Older and Adults

    Sponsor: argenx. Phase: PHASE2. Conditions: Autoimmune Encephalitis (AE)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06837454: French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

    Sponsor: Sanofi. Phase: . Conditions: Atopic Dermatitis

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04691154: A Phase 3 Study to Evaluate the Safety and Tolerability of L606 in Subjects With PAH or PH-ILD

    Sponsor: Liquidia Technologies, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension, Pulmonary Hypertension Due to Lung Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04889105: Exercise Therapy for PAD Using Mobile Health

    Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Peripheral Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07675005: The Prospective, Multicenter, Randomized Controlled Trial of the VentriCure Interventional Left Ventricular Assist System

    Sponsor: Life Shield Medical Technology Co., LTD. Phase: NA. Conditions: Coronary Artery Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07482605: Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

    Sponsor: Jiangmen Central Hospital. Phase: PHASE2. Conditions: Lung Cancer (NSCLC), Malignant Pleural Effusions (Mpe)- Pleurodesis

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07460505: Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure

    Sponsor: National University Hospital, Singapore. Phase: NA. Conditions: Heart Failure, OSA - Obstructive Sleep Apnea

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02502266: Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer

    Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fallopian Tube Undifferentiated Carcinoma, Ovarian Clear Cell Adenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Adenocarcinoma, Ovarian Transitional Cell Carcinoma, Ovarian Undifferentiated Carcinoma, Primary Peritoneal Serous Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04214756: Methodist Acute Pancreatitis Protocol

    Sponsor: Methodist Health System. Phase: . Conditions: Acute Pancreatitis (AP)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04562766: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)

    Sponsor: Principia Biopharma, a Sanofi Company. Phase: PHASE3. Conditions: Immune Thrombocytopenia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07243756: Gut Microbiome Pill

    Sponsor: NYU Langone Health. Phase: NA. Conditions: Healthy

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07425756: taVNS Combined With TENS on Motor Function in Stroke

    Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07380256: Visual Influences on Vestibular Adaptation

    Sponsor: Emory University. Phase: NA. Conditions: Vestibular Hypofunction, Binocular Vision Abnormalities, Reduced Vision

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03494322: EACH: Evaluating Avelumab in Combination With Cetuximab in Head and Neck Cancer

    Sponsor: University College, London. Phase: PHASE2. Conditions: Head and Neck Cancer, Squamous Cell Carcinoma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06465329: A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

    Sponsor: Regeneron Pharmaceuticals. Phase: PHASE2. Conditions: Non-Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07669402: Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia.

    Sponsor: Tehran University of Medical Sciences. Phase: PHASE2. Conditions: Idiopathic Oligoasthenoteratozoospermia, Male Infertility

    full page →ctgov ↗
    ›WITHHELDphase readoutNCT07354802: [Trial of device that is not approved or cleared by the U.S. FDA]

    Sponsor: [Redacted]. Phase: . Conditions:

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07209202: Fructose Intestinal Gluconeogenesis

    Sponsor: Touro University, California. Phase: NA. Conditions: Healthy Participants, Obese But Otherwise Healthy Participants

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04991402: Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

    Sponsor: Columbia University. Phase: . Conditions: HIV, Obesity, Obesity, Infant, Maternal Obesity During Childbirth, Maternal Obesity Complicating Pregnancy

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06473831: MagDI Australia Study

    Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Obesity, Type 2 Diabetes

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT00496522: Proton Beam Therapy for Chondrosarcoma

    Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Chondrosarcoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07049822: Optimising Mammography Screening Accuracy With Blood-based Biomarkers

    Sponsor: Vejle Hospital. Phase: . Conditions: Breast Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07549022: Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor

    Sponsor: Ankit Mangla, MD. Phase: PHASE1. Conditions: Malignant Peripheral Nerve Sheath Tumors, MPNST

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07370922: Glucagon-Like Peptide 1 Receptor Agonist in Diabetes Mellitus Management in Children and Adolescents With Transfusion-Dependent Thalassemia

    Sponsor: Ain Shams University. Phase: PHASE2. Conditions: Transfusion Dependent Beta Thalassemia

    full page →ctgov ↗
    ← prev
    page 99 of 108
    next →